Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-3-14
pubmed:abstractText
Angiotensin II is a key mediator of diabetes-related vascular disease. It is now recognized that in addition to angiotensin-converting enzyme, chymase is an important alternative angiotensin II-generating enzyme in hypertension and diabetes. However, the mechanism of induction of chymase in diabetes remains unknown.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-10441104, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-10690317, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-10694521, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-11110735, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-11158035, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-11397777, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-11416217, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12003835, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12595493, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12675866, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12709399, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12819233, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-12819257, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-13678869, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-14670831, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-14693930, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15039226, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15173164, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15220206, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15224502, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15380935, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15464056, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15539106, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15620429, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15644622, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-15686787, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-2266130, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-7822770, http://linkedlifedata.com/resource/pubmed/commentcorrection/16520412-8521302
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
113
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1353-60
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.
pubmed:affiliation
Department of Medicine-Nephrology, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural